Vaccinex (VCNX) SEC Filings & 10K Form $0.66 -0.03 (-4.35%) As of 05/21/2025 09:38 AM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Vaccinex SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/15/20254:12 PMVaccinex (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 04/01/20256:01 AMVaccinex (Filer)Form NT 10-K03/27/20257:24 AMVaccinex (Filer)Form 15-12G03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/202511:15 PMVaccinex (Filer)Form EFFECT03/25/20257:38 AMVaccinex (Filer)Form POS AM03/25/20257:40 AMVaccinex (Filer)Form POS AM03/25/20257:41 AMVaccinex (Filer)Form POS AM03/25/20257:43 AMVaccinex (Filer)Form POS AM03/25/20257:45 AMVaccinex (Filer)Form POS AM03/25/20257:46 AMVaccinex (Filer)Form POS AM03/25/20257:48 AMVaccinex (Filer)Form POS AM03/25/20257:50 AMVaccinex (Filer)Form POS AM03/25/20257:51 AMVaccinex (Filer)Form POS AM03/25/20257:24 AMVaccinex (Filer)Form S-8 POS03/25/20257:26 AMVaccinex (Filer)Form S-8 POS03/25/20257:28 AMVaccinex (Filer)Form POS AM03/25/20257:30 AMVaccinex (Filer)Form POS AM03/25/20257:31 AMVaccinex (Filer)Form POS AM03/25/20257:34 AMVaccinex (Filer)Form POS AM03/25/20257:35 AMVaccinex (Filer)Form POS AM03/25/20257:36 AMVaccinex (Filer)Form POS AM03/19/20253:15 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/07/20254:21 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/14/20253:43 PMARMISTICE CAPITAL, LLC (Filed by)Vaccinex (Subject)Form SCHEDULE 13G/A12/17/20248:32 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/18/20243:15 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A10/25/20243:11 PMVaccinex (Filer)Form 424B3Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma10/24/202411:15 PMVaccinex (Filer)Form EFFECT10/16/20243:44 PMVaccinex (Filer)Form S-3Registration statement under Securities Act of 1933 10/09/20243:37 PMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/27/20243:11 PMVaccinex (Filer)Form DNotice of Exempt Offering of Securities 09/20/20244:15 PMFCMI Parent Co. (Filed by)Vaccinex (Subject)Form SC 13D/A09/20/20243:57 PMVaccinex (Subject)Zauderer Maurice (Filed by)Form SC 13D/A09/19/20247:30 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/20/20245:04 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20244:17 PMVaccinex (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/14/20247:35 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/31/20248:05 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/08/20243:16 PMVaccinex (Filer)Form 424B307/07/202411:15 PMVaccinex (Filer)Form EFFECT06/27/20243:41 PMVaccinex (Filer)Form S-3Registration statement under Securities Act of 1933 06/06/20247:36 AMVaccinex (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Acurx Pharmaceuticals SEC Filings Biomerica SEC Filings Brainstorm Cell Therapeutics SEC Filings Phio Pharmaceuticals SEC Filings BioXcel Therapeutics SEC Filings Neuphoria Therapeutics Inc. - Common Stock SEC Filings Addex Therapeutics SEC Filings Sensei Biotherapeutics SEC Filings Portage Biotech SEC Filings Ainos SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:VCNX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
